Condition Lookup

Diabetic Ketoacidosis (DKA)

Specialty: Diabetes and Endocrinology

Category: Diabetes Mellitus and Related Disorders

Symptoms:
excessive thirst; frequent urination; nausea; vomiting; abdominal pain; shortness of breath; fruity-smelling breath; confusion

Root Cause:
Insulin deficiency leads to uncontrolled hyperglycemia, lipolysis, and ketone production, causing metabolic acidosis.

How it's Diagnosed: videos
Blood tests showing high blood glucose, ketonemia, low bicarbonate, and arterial blood pH < 7.3; urine tests for ketones.

Treatment:
Intravenous fluids, insulin therapy, electrolyte replacement (potassium), and treating underlying causes (e.g., infection).

Medications:
Regular insulin administered intravenously to reduce blood glucose and ketone levels.

Prevalence: How common the health condition is within a specific population.
Common in individuals with type 1 diabetes; can occur in type 2 diabetes during severe stress.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Poor diabetes management, infection, trauma, surgery, or missed insulin doses.

Prognosis: The expected outcome or course of the condition over time.
Early treatment leads to recovery; delayed treatment may result in coma or death.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Cerebral edema, hypokalemia, arrhythmias, and death.

Autoimmune destruction of pancreatic beta cells (Type 1 Diabetes)

Specialty: Diabetes and Endocrinology

Category: Diabetes Mellitus and Related Disorders

Sub-category: Type 1 Diabetes Mellitus

Symptoms:
frequent urination (polyuria); excessive thirst (polydipsia); unintended weight loss; fatigue; blurred vision; slow wound healing; recurrent infections

Root Cause:
The immune system attacks and destroys insulin-producing beta cells in the pancreas, leading to a lack of insulin production and resul.ting in hyperglycemia.

How it's Diagnosed: videos
Diagnosed by hyperglycemia, autoantibodies (e.g., GAD, ICA), and low C-peptide levels.

Treatment:
Treated with insulin therapy and blood glucose monitoring.

Medications:
Insulin is the primary treatment, including long-acting (e.g., glargine , detemir ) and short-acting (e.g., lispro, aspart) insulin analogs. These are classified as hormone replacement therapies.

Prevalence: How common the health condition is within a specific population.
Accounts for approximately 5–10% of all diabetes cases; often diagnosed in childhood but can occur at any age.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Family history of type 1 diabetes, presence of other autoimmune conditions, certain genetic markers (e.g., HLA-DR3, HLA-DR4), and environmental triggers (e.g., viral infections).

Prognosis: The expected outcome or course of the condition over time.
Lifelong management with insulin therapy is required. With proper treatment, individuals can lead normal, healthy lives, although there is an increased risk of complications if poorly managed.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Diabetic ketoacidosis (DKA), chronic complications like retinopathy, nephropathy, neuropathy, and an increased risk of cardiovascular disease.

Latent Autoimmune Diabetes in Adults (LADA)

Specialty: Diabetes and Endocrinology

Category: Diabetes Mellitus and Related Disorders

Sub-category: Type 2 Diabetes Mellitus

Symptoms:
gradual onset of hyperglycemia; excessive thirst (polydipsia); frequent urination (polyuria); fatigue; blurred vision; weight loss

Root Cause:
A slow-progressing autoimmune destruction of pancreatic beta cells, resulting in reduced insulin production. Often misdiagnosed as type 2 diabetes due to its slower progression.

How it's Diagnosed: videos
Diagnosed through positive islet autoantibodies and gradual insulin dependence.

Treatment:
Treated initially with oral antidiabetics (e.g., metformin) and progression to insulin therapy as beta-cell function declines.

Medications:
Initially, oral medications such as metformin or sulfonylureas may be used. Insulin therapy becomes necessary as the disease progresses. Insulin is classified as a hormone replacement therapy.

Prevalence: How common the health condition is within a specific population.
Accounts for approximately 5–10% of all diabetes cases; more common in adults over 30 but often underdiagnosed.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Family history of autoimmune conditions, genetic predisposition (e.g., certain HLA genes), and environmental factors.

Prognosis: The expected outcome or course of the condition over time.
With early diagnosis and treatment, blood sugar levels can be effectively managed. Delayed diagnosis may increase the risk of complications.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Similar to type 1 diabetes, including an increased risk of retinopathy, nephropathy, neuropathy, and cardiovascular complications.

Insulin Resistance and Relative Insulin Deficiency

Specialty: Diabetes and Endocrinology

Category: Diabetes Mellitus and Related Disorders

Sub-category: Type 2 Diabetes Mellitus

Symptoms:
increased hunger (polyphagia); frequent urination (polyuria); excessive thirst (polydipsia); fatigue; blurred vision; slow-healing wounds; darkened skin patches (acanthosis nigricans)

Root Cause:
Impaired cellular response to insulin leads to reduced glucose uptake, causing the pancreas to overproduce insulin to compensate. This contributes to beta-cell dysfunction and relative insulin deficiency over time.

How it's Diagnosed: videos
Blood tests such as fasting glucose levels, HbA1c (glycated hemoglobin), oral glucose tolerance test (OGTT), and insulin levels; physical exam identifying symptoms like acanthosis nigricans.

Treatment:
Lifestyle interventions (diet, exercise), weight management, medications to improve insulin sensitivity or lower blood glucose, and in some cases, insulin therapy.

Medications:
Metformin

Prevalence: How common the health condition is within a specific population.
Insulin resistance is a hallmark of prediabetes and Type 2 diabetes, affecting up to 39% of the global adult population, with higher rates in obese and sedentary individuals.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Obesity, sedentary lifestyle, family history of diabetes, polycystic ovary syndrome (PCOS), age over 45, and certain ethnicities (e.g., African American, Hispanic, Asian).

Prognosis: The expected outcome or course of the condition over time.
With proper management, progression to diabetes can be delayed or prevented. Uncontrolled, it leads to chronic hyperglycemia and complications such as cardiovascular disease and neuropathy.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Increased risk of Type 2 diabetes, cardiovascular disease, fatty liver disease, kidney damage, and nerve damage (neuropathy).

Diabetes during pregnancy

Specialty: Diabetes and Endocrinology

Category: Diabetes Mellitus and Related Disorders

Sub-category: Gestational Diabetes Mellitus (GDM)

Symptoms:
increased thirst; frequent urination; fatigue; blurred vision; unexplained weight changes; nausea; slow-healing infections

Root Cause:
Insulin resistance due to hormonal changes during pregnancy, combined with an inability of the pancreas to produce sufficient insulin to maintain normal glucose levels.

How it's Diagnosed: videos
Diagnosis is through glucose screening tests such as the oral glucose tolerance test (OGTT) conducted during the second trimester (usually between 24 and 28 weeks of pregnancy).

Treatment:
Management involves dietary modifications, regular physical activity, blood glucose monitoring, and, if needed, medications to regulate blood sugar levels.

Medications:
Insulin therapy is the primary treatment if blood sugar cannot be controlled through lifestyle changes. Additionally, oral medications such as metformin (a biguanide that improves insulin sensitivity) or glyburide (a sulfonylurea that increases insulin secretion) may be prescribed in some cases.

Prevalence: How common the health condition is within a specific population.
Gestational diabetes affects approximately 6-9% of pregnancies globally, with higher rates in certain populations.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Family history of diabetes; overweight or obesity; advanced maternal age; previous history of gestational diabetes; ethnic predisposition (e.g., South Asian, African-American, Hispanic); polycystic ovary syndrome (PCOS)

Prognosis: The expected outcome or course of the condition over time.
Most women with gestational diabetes return to normal glucose levels after delivery. However, they remain at higher risk of developing type 2 diabetes in the future.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Macrosomia (large baby size); increased risk of cesarean delivery; neonatal hypoglycemia; respiratory distress syndrome in newborn; increased risk of preeclampsia for the mother; future metabolic disorders in both mother and child

Neonatal Diabetes

Specialty: Diabetes and Endocrinology

Category: Diabetes Mellitus and Related Disorders

Sub-category: Other Specific Types of Diabetes

Symptoms:
failure to thrive; dehydration; severe hyperglycemia; frequent urination; weight loss in newborns

Root Cause:
Genetic mutations affecting insulin production or secretion, typically presenting in the first six months of life.

How it's Diagnosed: videos
Genetic testing for mutations in genes like KCNJ11 or ABCC8; fasting glucose levels, C-peptide levels, and ketones.

Treatment:
Sulfonylureas in cases of ATP-sensitive potassium channel mutations, or insulin therapy if necessary.

Medications:
Sulfonylureas (e.g., glibenclamide) are commonly used; in some cases, insulin therapy is required to manage blood sugar levels.

Prevalence: How common the health condition is within a specific population.
Approximately 1 in 90,000 to 160,000 live births worldwide.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Genetic mutations, consanguinity, and family history of early-onset diabetes.

Prognosis: The expected outcome or course of the condition over time.
Varies depending on the mutation; many children achieve good control with oral medications, though some require lifelong insulin therapy.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Growth and developmental delays, diabetic ketoacidosis (DKA), and long-term microvascular or macrovascular complications.

Secondary Diabetes

Specialty: Diabetes and Endocrinology

Category: Diabetes Mellitus and Related Disorders

Sub-category: Other Specific Types of Diabetes

Symptoms:
hyperglycemia; frequent urination; excessive thirst; weight loss; symptoms related to the underlying condition (e.g., cushing’s syndrome or acromegaly)

Root Cause:
Insulin resistance or deficiency caused by an underlying medical condition (e.g., Cushing's syndrome, acromegaly) or medications (e.g., glucocorticoids).

How it's Diagnosed: videos
Blood glucose levels, HbA1c testing, OGTT, and assessment for underlying conditions via imaging or hormonal studies.

Treatment:
Managing the underlying condition, lifestyle changes, and glucose-lowering medications (e.g., metformin, insulin).

Medications:
Insulin for glycemic control; metformin to improve insulin sensitivity; glucocorticoid antagonists if due to steroid therapy.

Prevalence: How common the health condition is within a specific population.
Varies widely depending on the prevalence of underlying conditions (e.g., 2-4% of people on long-term steroid therapy develop secondary diabetes).

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Long-term glucocorticoid therapy, tumors affecting hormone production, genetic predisposition to insulin resistance.

Prognosis: The expected outcome or course of the condition over time.
Good with treatment of the underlying condition and proper glycemic control; outcomes depend on the severity of the primary disease.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Microvascular and macrovascular complications if glycemic control is not achieved, complications related to the primary condition.

Pancreatic Diabetes (Type 3c Diabetes)

Specialty: Diabetes and Endocrinology

Category: Diabetes Mellitus and Related Disorders

Sub-category: Other Specific Types of Diabetes

Symptoms:
chronic hyperglycemia; digestive issues (e.g., steatorrhea); weight loss; frequent urination; excessive thirst

Root Cause:
Damage to the pancreas due to chronic conditions like pancreatitis, cystic fibrosis, or pancreatic surgery, impairing insulin and digestive enzyme production.

How it's Diagnosed: videos
Fasting glucose, HbA1c, C-peptide levels, imaging of the pancreas (e.g., CT or MRI), and fecal elastase for exocrine insufficiency.

Treatment:
Insulin therapy for hyperglycemia, pancreatic enzyme replacement therapy (PERT) for digestive insufficiency, and dietary modifications.

Medications:
Insulin (short-acting and basal types) for glucose control; pancreatic enzyme replacements (e.g., pancrelipase ) for digestion.

Prevalence: How common the health condition is within a specific population.
Estimated in 5-10% of diabetes cases; underdiagnosed.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Chronic pancreatitis, cystic fibrosis, hemochromatosis, pancreatic surgery, or trauma.

Prognosis: The expected outcome or course of the condition over time.
Challenging to manage; requires coordinated care for endocrine and exocrine dysfunctions.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Severe hypoglycemia, malnutrition due to digestive enzyme deficiencies, and long-term complications of poorly controlled diabetes (e.g., retinopathy, nephropathy).

Diabetic Neuropathy (Peripheral)

Specialty: Diabetes and Endocrinology

Category: Diabetes Mellitus and Related Disorders

Sub-category: Diabetes-Related Complications

Symptoms:
numbness; tingling; burning pain; loss of sensation; weakness in the feet and hands

Root Cause:
Chronic high blood sugar damages peripheral and autonomic nerves by disrupting blood supply and oxidative stress mechanisms.

How it's Diagnosed: videos
Clinical examination, nerve conduction studies, electromyography (EMG), and tests for autonomic function (e.g., heart rate variability).

Treatment:
Blood sugar control, pain management, and supportive therapies for specific symptoms.

Medications:
For pain relief - pregabalin (anticonvulsant), duloxetine (SNRI), or gabapentin (anticonvulsant). For gastroparesis - metoclopramide (prokinetic agent). For autonomic symptoms - midodrine for orthostatic hypotension; bethanechol for urinary retention.

Prevalence: How common the health condition is within a specific population.
Affects approximately 50% of individuals with diabetes.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Long duration of diabetes, poor glycemic control, obesity, smoking, and hypertension.

Prognosis: The expected outcome or course of the condition over time.
Symptoms may improve with tight glycemic control, but nerve damage is often irreversible.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Foot ulcers, infections, amputations, cardiovascular complications, and reduced quality of life.

Diabetic Neuropathy (Autonomic)

Specialty: Diabetes and Endocrinology

Category: Diabetes Mellitus and Related Disorders

Sub-category: Diabetes-Related Complications

Symptoms:
gastroparesis; urinary incontinence; erectile dysfunction; dizziness upon standing; sweating abnormalities